These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9003)

  • 1. Bêta-adrenoreceptor blocking properties of 1-nitro, hydroxy phenyl, N-benzoyl alanine (GAL-1).
    Telang B; Galzigna L
    Agressologie; 1976; 17(1):43-8. PubMed ID: 9003
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blocking properties compared to other pharmacological and biochemical effects of 1, NO2-hydroxyphenyl, N-benzoyl-alanine (GAL-1).
    Galzigna L; Manani G; Bossi M; Scalella P; Mettifogo V
    Agressologie; 1976; 17(2):99-104. PubMed ID: 7962
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some aspects of the antagonism between GAL-I and isoproterenol].
    Manani G; Galzigna L; Bozza G; Scalella P; Bossi M; Sandei F; Giron GP
    Clin Ter; 1979 Oct; 91(1):11-8. PubMed ID: 44691
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacology of 1-phenylaminoethylamino-3-(phenoxy)propanol derivatives with beta-adrenergic action].
    Femmer K; Heer S; Poppe H
    Pharmazie; 1983 Jun; 38(6):409-14. PubMed ID: 6136994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmacology of (+/-)-1-(4-cyclohexylureido-phenoxy)-2-hydroxy-3-tert-butylaminopropane (Talinolol, Cordanum, 02-115)].
    Femmer K; Bartsch R; Leonhardt U; von Littrow C; Riedel H
    Pharmazie; 1975 Oct; 30(10):642-51. PubMed ID: 688
    [No Abstract]   [Full Text] [Related]  

  • 8. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
    Reyes G; Ramírez T; Hong E
    Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
    [No Abstract]   [Full Text] [Related]  

  • 9. [A search for new beta-adrenoblockaders in the series of 5-phenoxymethyl-1,2,4-oxadiazole derivatives].
    Mashkovskiĭ MD; Iuzhakov SD
    Eksp Klin Farmakol; 1994; 57(3):27-30. PubMed ID: 7914114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electromechanical effects of newly synthetized propafenone derivatives on isolated guinea-pig heart muscle preparations.
    Studenik C; Lemmens-Gruber R; Heistracher P; Ecker G; Maxl A; Fleischhacker W
    Arzneimittelforschung; 1996 Feb; 46(2):134-8. PubMed ID: 8720301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective beta(1)-adrenoreceptor blocking activity of newly synthesized acyl amino-substituted aryloxypropanolamine derivatives, DPJ 955 and DPJ 890, in rats.
    Nandakumar K; Bansal SK; Singh R; Bodhankar SL; Jindal DP; Coumar MS; Balaraman R; Bhardwaj SH
    J Pharm Pharmacol; 2005 Apr; 57(4):515-9. PubMed ID: 15831214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenoreceptor blocking properties of new thienylethanolamine derivatives.
    Darias V; Madroñero R; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1751-6. PubMed ID: 4155632
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Puerarin beta-adrenergic receptor blocking effect.
    Lu XR; Gao E; Xu LZ; Li HZ; Kang B; Chen WN; Chen SM; Chai XS
    Chin Med J (Engl); 1987 Jan; 100(1):25-8. PubMed ID: 2885157
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta adrenoceptor blocking properties of MK-761.
    Sweet CS; Hall RA; Columbo JM; Wenger HC; Backlund E; Morgan G; Gaul SL; Scriabine A
    J Pharmacol Exp Ther; 1979 Oct; 211(1):195-9. PubMed ID: 40012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-adrenoceptor blockade with diphenylhydantoin (DPH).
    Shah UH; Jindal MN; Patel VK
    Arzneimittelforschung; 1977; 27(12):2316-8. PubMed ID: 23797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta-adrenoblocking activity and other pharmacological properties of 2-(3-amino-2-hydroxypropoxy)phenyoxymethyl isoxazole derivatives].
    Iuzhakov SD; Zaĭtseva KA; Dorodnikova EV; Mashkovskiĭ MD
    Farmakol Toksikol; 1985; 48(3):36-40. PubMed ID: 2863169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sodium ascorbate on rat uterus and guinea pig atria in vitro.
    Varma RK; Kaushal R
    Indian J Physiol Pharmacol; 1987; 31(1):73-5. PubMed ID: 3666877
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the new beta-adrenolytic compound propyl-3-acetyl-4-[(2-hydroxy-3-isopropylamino) propoxy]carbanylate hydrochloride on isolated heart muscle.
    Knezl V; Magna D; Sotníková R; Drímal J
    Arzneimittelforschung; 1994 Jan; 44(1):7-12. PubMed ID: 7907875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.